Alex Andre - Feb 13, 2025 Form 4 Insider Report for Algorhythm Holdings, Inc. (RIME)

Signature
/s/ Alex Andre
Stock symbol
RIME
Transactions as of
Feb 13, 2025
Transactions value $
$0
Form type
4
Date filed
2/18/2025, 05:01 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RIME Common Stock Award $0 +23.8K $0.00 23.8K Feb 13, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RIME Stock Option (right to buy) Award $0 +23.8K $0.00 23.8K Feb 13, 2025 Common Stock 23.8K $2.78 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction involved the Reporting Person's receipt of a restricted stock award for 23,818 shares of the Issuer's common stock. The restricted stock award was granted by the Board of Directors of the Issuer as an inducement grant pursuant to the Nasdaq Listing Rule 5635(c)(4). Twenty-five percent (25%) of the total number of shares subject to the restricted stock award shall vest on the first anniversary of the grant date and six and one-quarter percent (6.25%) of the remaining shares shall vest each quarter thereafter.
F2 The reported transaction involved the Reporting Person's receipt of a non-qualified stock option to purchase 23,818 shares of the Issuer's common stock. The non-qualified stock option was granted by the Board of Directors of the Issuer as an inducement grant pursuant to the Nasdaq Listing Rule 5635(c)(4).
F3 Twenty-five percent (25%) of the total number of shares subject to the non-qualified stock option shall vest and become exercisable on the first anniversary of the grant date and six and one-quarter percent (6.25%) of the remaining shares shall vest and become exercisable each quarter thereafter.